Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
21,448 | $0 | 1,551,261 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
2,537 | $1.2 | 1,551,261 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-05 6:10 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
18,911 | $1.69 | 1,551,261 (Direct) |
View |
| 2023-12-11 Exercise |
2023-12-14 4:00 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
8,840 | $0 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
2,536 | $1.2 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-12-14 4:00 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
6,304 | $1.69 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
84,637 | $0 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
27,900 | $1.2 | 1,324,309 (Direct) |
View |
| 2023-11-20 Exercise |
2023-11-22 1:48 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
56,737 | $1.69 | 1,324,309 (Direct) |
View |
| 2023-02-03 Option Award |
2023-02-07 4:08 pm |
N/A 2033-02-03 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
302,600 | $0 | 1,286,336 (Direct) |
View |
| 2023-01-13 Option Award |
2023-02-07 4:08 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
5,000 | $1.49 | 1,286,336 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A 2028-12-10 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
136,782 | $0 | 1,011,709 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
30,437 | $1.2 | 1,011,709 (Direct) |
View |
| 2022-12-21 Exercise |
2022-12-23 4:47 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
106,345 | $1.03 | 1,011,709 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 5:02 pm |
N/A 2032-02-22 |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD President and CEO |
106,200 | $0 | 106,200 (Direct) |
View |
Ownership |
2021-06-17 9:13 pm |
N/A N/A |
Cyteir Therapeutics Inc. | CYT | RENSCHLER MARKUS MD See Remarks |
0 | $0 | 1,512,048 (Direct) |
View |